Scientific article
OA Policy
English

Estimates of the duration of the early and late stage of gambiense sleeping sickness

Published in

BMC infectious diseases, vol. 8, 16

Publication date

2008

Abstract

BACKGROUND: The durations of untreated stage 1 (early stage, haemo-lymphatic) and stage 2 (late stage, meningo-encephalitic) human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense are poorly quantified, but key to predicting the impact of screening on transmission. Here, we outline a method to estimate these parameters. METHODS: We first model the duration of stage 1 through survival analysis of untreated serological suspects detected during Médecins Sans Frontières interventions in Uganda and Sudan. We then deduce the duration of stage 2 based on the stage 1 to stage 2 ratio observed during active case detection in villages within the same sites. RESULTS: Survival in stage 1 appears to decay exponentially (daily rate = 0.0019; mean stage 1 duration = 526 days [95%CI 357 to 833]), possibly explaining past reports of abnormally long duration. Assuming epidemiological equilibrium, we estimate a similar duration of stage 2 (500 days [95%CI 345 to 769]), for a total of nearly three years in the absence of treatment. CONCLUSION: Robust estimates of these basic epidemiological parameters are essential to formulating a quantitative understanding of sleeping sickness dynamics, and will facilitate the evaluation of different possible control strategies.

Keywords

  • Adolescent
  • Adult
  • Animals
  • Child
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Prevalence
  • Sudan/epidemiology
  • Trypanosoma brucei gambiense
  • Trypanosomiasis, African/diagnosis/epidemiology
  • Uganda/epidemiology

UNIGE research groups

Citation (ISO format)

CHECCHI, Francesco et al. Estimates of the duration of the early and late stage of gambiense sleeping sickness. In: BMC infectious diseases, 2008, vol. 8, p. 16. doi: 10.1186/1471-2334-8-16

Main files (1)

Article (Accepted version)

Identifiers

Additional URL for this publication

http://www.biomedcentral.com/1471-2334/8/16

Journal ISSN

1471-2334
621views
411downloads

Technical informations

Creation

04/06/2009 09:48:00

First validation

04/06/2009 09:48:00

Update

14/03/2023 15:06:10

Status update

14/03/2023 15:06:10

Last indexation

29/10/2024 11:39:54
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated